Abstract: An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of Magnolia, an extract of Phellodendron, and a whey protein.
Type:
Grant
Filed:
January 25, 2021
Date of Patent:
September 12, 2023
Assignee:
NUTRAMAX LABORATORIES, INC.
Inventors:
Todd Henderson, David Griffin, David Bledsoe
Abstract: Compositions and methods for amelioration of skin laxity and body contour are provided. Provided herein are compositions comprising a combination of peptides.
Abstract: An enhanced food composition in the form of a soup, sauce, condiment or seasoning is described, the enhanced food composition comprising a nitrate-containing vegetable, such as beetroot effectively mixed with a salt content at a specified ratio. The enhanced food composition has the effect to prevent an increase in blood pressure while masking the bad taste of the nitrate-containing vegetable.
Abstract: A method useful for providing a phytonutrient to a subject via mediation of the subject's microbiome is disclosed. The method includes administering a phytofunctional composition to a subject change the phytonutrient producer status of the subject. The method may also include identifying a phytonutrient producer status of the subject by assessing a level of at least one of a preselected phytonutrient and a preselected phytonutrient precursor compound within the subject. A phytofunctional composition useful in the method is also disclosed, and comprises a phytonutrient precursor compound and an active agent. The active agent comprises a probiotic and/or a prebiotic, and is adapted to mediate production of the preselected phytonutrient in the gastrointestinal tract of the subject, thereby changing the phytonutrient producer status of the subject.
Abstract: The present invention relates to a method for preparing a bird's nest extract and the various extracts obtained from said method. In an aspect of the present invention, there is provided a method for preparing a bird's nest extract, the extract comprising at least one molecule obtained from edible bird's nest (EBN), the method comprising the steps of: (a) washing raw EBN; (b) filtering the washed EBN; (c) extracting the molecule from the EBN; and (d) isolating the molecule.
Abstract: Disclosed herein are ionic aqueous compositions useful as nasal passage washes to aid in the resorption of edema of the respiratory mucosa, e.g., the nasal mucosa, for the treatment of respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis, sinusitis, allergic rhinitis and nasal polyps. The composition includes an ionic aqueous solution and algae-derived constituents, such as branched, sulfated polysaccharides having an average molecular weight greater than 4 kDa and comprising L-fucose and sulfate ester groups or extracts from brown algae. Also disclosed are methods and pharmaceutical compositions for treating respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis.
Abstract: Systems and methods of the invention generally relate to prolonging viability of bodily tissue, especially lung tissue, through the use of an expandable accumulator to maintain a constant pressure within the lumen of the organ even during external pressure fluctuations due to, for example, flight. Systems and methods may include prolonging donor organ viability in storage through the use of an organ container that mimics the geometry and orientation of the organ in vivo.
Type:
Grant
Filed:
July 16, 2021
Date of Patent:
May 30, 2023
Assignee:
Paragonix Technologies, Inc.
Inventors:
Jared Alden Judson, Lisa Maria Anderson, William Edelman
Abstract: The present invention describes a method of killing or inactivating microorganisms, the method comprising the steps of contacting the microorganisms with a composition comprising an extract of Polygonum cuspidatum and an excipient; and irradiating the microorganisms with a source of light; wherein the radiant exposure of the light is between 1 and 300 J cm?2, and the surface power density of the light is between 0.001 and 0.25 W cm?2.
Abstract: A particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention is isolated from excrement of a human or cabbage kimchi, and thus is highly safe and has physiological activities such as an immunity regulatory effect and an inflammation reaction inhibiting effect. Therefore, the particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention may be used as a material for regulating immunity and inhibiting inflammation reactions, and may be also used as a functional food and drug material useful for preventing, alleviating or treating rhinitis, atopy, asthma, etc. which are allergic diseases.
Type:
Grant
Filed:
January 31, 2018
Date of Patent:
May 30, 2023
Assignees:
UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY, NAVIPHARM CO., LTD.
Abstract: The present invention relates to, inter alia, compositions and methods, including therapeutic alkaline phosphatases that find use in the treatment or prevention of the effects of radiation exposure and/or chemotherapy.
Type:
Grant
Filed:
March 20, 2019
Date of Patent:
May 23, 2023
Assignee:
Theriva Biologics, Inc.
Inventors:
Michael Kaleko, Christian Furlan Freguia, Sheila Connelly
Abstract: A composition comprising an extract of Trigonella foenum Graecum, Fenugreek and Cinnamon administered in high doses is capable of arresting the formation Glocotoxicity and Lipotoxicity which lead to Insulin Resistance (IR), the hall mark of Type 2 Diabetes (T2DM). Natural ingredients with similar properties to Fenugreek and Cinnamon are used in the composition to function in synergy with the Fenugreek and Cinnamon to control IR and to minimize any undesirable side effects of using the high doses of Fenugreek and Cinnamon. Use of the composition results in a significant reduction of IR with a remarkable improvement in health in subjects suffering either from pre-diabetes and/or from T2DM.
Abstract: The invention relates to a purified xanthophyll composition comprising (trans,R R)-lutein and (trans,R,R)-zeaxanthin, which is comprised of more than 80% of total xanthophylls and a process for the preparation thereof. Purified xanthophyll composition is comprised of selective isomers such as at least 85% by weight of (trans,R,R)-lutein and at least 15% by weight of (trans,R,R)-zeaxanthin. The composition is prepared by process of extraction from two different plant sources using industrially viable process and purified by employing food grade polar and non-polar solvents. The invention relates to purified xanthophyll composition which is selectively free from (R,S)-zeaxanthin and is suitable for human consumption.
Abstract: Described herein are compositions and methods of treating a cardiac condition using modified placental tissue or an extract of a placental tissue, capable of recruiting stem cells or promoting healing in vivo and in vitro.
Type:
Grant
Filed:
January 15, 2021
Date of Patent:
May 16, 2023
Assignee:
MiMedx Group, Inc.
Inventors:
Thomas J. Koob, Hubbard Frank Burrows, III
Abstract: The invention is directed to a composition comprising a green tea flower extract and methods for making and using the composition in the management of a healthy body weight. The composition can comprise an aqueous alcohol extract of Camellia sinensis that is administered to a patient to provide a method for maintaining a healthy body weight.
Abstract: Disclosed is a composition for preventing or inhibiting influenza virus infection, containing ginseng berry polysaccharides as active ingredients, and the ginseng berry polysaccharides exhibit an inhibitory effect on influenza virus activity or infection due to specific ingredients and structures and, specifically, have an excellent inhibitory effect on neuraminidase activity.
Type:
Grant
Filed:
April 26, 2019
Date of Patent:
May 9, 2023
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Donghyun Cho, Suhwan Kim, Juewon Kim, Chan Woong Park, Dae Bang Seo
Abstract: The method for a skin treatment using a first snail on a human patient includes placing the first snail on a first surface to allow the first snail to attach itself to the first surface. The method further includes projecting a first predetermined amount of a first agent onto the first snail with to cause the first snail to secrete a liquid on the first surface. The method further includes administering the secreted liquid over a surface of a skin of a portion of a body of the human patient.
Abstract: The present disclosure encompasses compositions prepared from kiwifruit. In particular, the invention encompasses compositions prepared from gold varieties of Actinidia chinensis. Also encompassed are methods of preparing these compositions. Further encompassed are methods of using these compositions, in particular, for treating or preventing disorders of the gastrointestinal system, including amongst others: inflammation, constipation, bowel irregularity, microbiota imbalances, irritable bowel syndrome, and inflammatory bowel disease.
Abstract: Provided are: a method for producing a nasal drop composition suitable for treatment or prevention of a disease or symptom in the nasal cavities; and a nasal drop composition produced by the production method. The nasal drop composition production method characterized by including a mixing step of mixing earthworm castings with water and a collecting step of collecting vaporized water generated from a mixture obtained in the mixing step to obtain a liquid; and the nasal drop composition produced by the production method. It is preferred to further mix an organic substance together with the earthworm castings and the water in the mixing step.
Abstract: The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (?)-gallocatechin gallate (GCG) and (?)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.
Type:
Grant
Filed:
February 18, 2021
Date of Patent:
April 25, 2023
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Hyungsu Kim, Si Young Cho, A Young Kim, Wonseok Park, Yong Deog Hong
Abstract: The present disclosure provides an extract of early-harvested Citrus reticulata fruit, and a method for reducing lipid accumulation by using the extract of early-harvested Citrus reticulata fruit. The extract of early-harvested Citrus reticulata fruit includes tetramethylisoscutellarein.